Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Preventive effect of stimulants on the risk of brain injuries had been reported. The aim of this study is to determine the extent to which methylphenidate (MPH) prescription moderates the risk of traumatic brain injuries (TBI) in individuals with attention-deficit/hyperactivity disorder (ADHD). Individuals with a recent diagnosis of ADHD between January 1997 and December 2013 (n = 163,618) were identified from Taiwan's National Health Insurance Research Database. A total of 124,438 adolescents and children with ADHD and without prior TBI diagnoses were included and evaluated for subsequent TBI. Methylphenidate prescription duration was subgrouped by the annual average cumulative defined daily dose (DDD): 0, >0 to ≤28, > 28 to ≤84, and >84. We identified 11,463 diagnoses of TBI among 124,438 adolescents and children with ADHD. A Cox regression model was used to investigate whether MPH prescription influenced the risk for TBI after adjusting for sex, age, level of urbanization, seizure, autism and sedative-anxiolytics use. A reduced TBI incidence was observed with MPH prescription DDDs > 84. The protective effect of MPH against TBI persisted after adjusting for confounding factors [hazard ratio (HR) = 0.49; 95% confidence interval (CI): 0.47-0.51]. There was also statistically significant difference in risk for TBI in subjects receiving > 0 to ≤28 or >28 to ≤84 DDDs of MPH treatment (HR = 0.88, 95% CI = 0.83-0.92; HR = 0.76, 95% CI = 0.72-0.80, respectively) when compared with…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A Taiwanese study of over 124,000 youths with ADHD found that methylphenidate treatment decreased the risk for traumatic brain injuries, after adjusting for confounders”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as Liao et al., 2018
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346 · cited 1×
“Attention-deficit/hyperactivity disorder (ADHD) is one of the most common mental disorders of children and adolescents with an estimated prevalence of approximately 5–8% among individuals under age 18 years [1].”
BackgroundBarkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199 · cited 1×
“In addition, individuals with ADHD are at a much higher risk for motor vehicle accidents and injuries, underscoring the public health significance of ADHD [7, 8].”
BackgroundYoung Adult Outcome of Hyperactive Children: Adaptive Functioning in Major Life Activities
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000189134.97436.e2 · Cited by 1,027 · cited 2×
“For example, longitudinal studies of children and young adults with ADHD consistently report lower academic and occupational achievement and higher rates of incarceration, depression, and divorce when compared with control groups [3].”
BackgroundMedication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611 · cited 1×
“In previous studies [16, 22], a patient with ADHD was defined as under medication treatment during the interval between two prescriptions, unless the two prescriptions occurred more than 6 months apart.”
MethodCheng, C.-L., Lee, C.-H., Chen, P.-S., Li, Y.-H., Lin, S.-J., & Yang, Y.-H. K. (2014) · Journal of Epidemiology · doi:10.2188/jea.je20140076 · Cited by 521
Self-citation(2010) · PsycEXTRA Dataset · doi:10.1037/e664852010-002 · Cited by 456
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293
Childhood Psychiatric Disorder and Unintentional Injury: Findings from a National Cohort Study
Rowe, R. (2004) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsh015 · Cited by 212 · cited 1×
“, antipsychotics, hypnotics), may also increase the risk for injury [6, 11].”
BackgroundSikirica, V., Lu, M., Greven, P., Zhong, Y., Qin, P., Xie, J., & Gajria, K. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65721 · Cited by 206 · cited 1×
“Non-adherence with recommended dose and/or duration of stimulant therapy for individuals with ADHD has been amply reported [18, 19].”
BackgroundDalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H. S., & Simonsen, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00271-0 · Cited by 170 · cited 1×
“5% of reduction in the prevalence of various kinds of injuries among ADHD children was found [25].”
BackgroundEpidemiology of traumatic brain injury in children receiving intensive care in the UK
Parslow, R. C. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2005.072405 · Cited by 166
Schweren, L., de Zeeuw, P., & Durston, S. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.014 · Cited by 116 · cited 2×
“Neuroadaptive and neurochemical changes may explain the dosage effect of stimulants [32, 33].”
BackgroundMethylphenidate and the risk of trauma
Man, K. K. C., Chan, E. W., Coghill, D., Douglas, I., Ip, P., Leung, L.-P., Tsui, M. S. H., Wong, W. H. S., & Wong, I. C. K. (2015) · Pediatrics · doi:10.1542/peds.2014-1738 · Cited by 108 · cited 3×
“The high prevalence and rising trajectory of TBI incidence invite the need to identify both risk and protective factors for TBI in the general and at-risk populations [4, 14].”
BackgroundRoad-Crossing Safety in Virtual Reality: A Comparison of Adolescents With and Without ADHD
Clancy, T. A., Rucklidge, J. J., & Owen, D. (2006) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3502_4 · Cited by 100
Role of executive function in ADHD.
Swanson, J. M. (2003) · PubMed · Cited by 94
Clemow, D. B., & Bushe, C. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115602489 · Cited by 73 · cited 1×
“Available evidence indicates that the full therapeutic effect of stimulant treatment on ADHD core symptoms might not be observed until 24 weeks post-initiation of treatment, which provided an adequate dosage of stimulants [28, 29].”
BackgroundAduen, P. A., Kofler, M. J., Cox, D. J., Sarver, D. E., & Lunsford, E. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.009 · Cited by 71
Fredriksen, M., Dahl, A. A., Martinsen, E. W., Klungsøyr, O., Haavik, J., & Peleikis, D. E. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.09.013 · Cited by 69 · cited 1×
“Increased adherence to stimulants is associated with improvements in core symptoms and cognitive performance in children and adolescents with ADHD [30, 31].”
BackgroundAmiri, A., Torabi Parizi, G., Kousha, M., Saadat, F., Modabbernia, M.-J., Najafi, K., & Atrkar Roushan, Z. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.07.018 · Cited by 58
Clinical coding: completeness and accuracy when doctors take it on.
Yeoh, C., & Davies, H. (1993) · BMJ · doi:10.1136/bmj.306.6883.972 · Cited by 57 · cited 1×
“The accuracy of disease diagnoses in the National Health Insurance system had been reported between 60 and 90% [36] and one study revealed the positive predictive value of 0.”
BackgroundMikolajczyk, R., Horn, J., Schmedt, N., Langner, I., Lindemann, C., & Garbe, E. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.3275 · Cited by 51 · cited 3×
“The high prevalence and rising trajectory of TBI incidence invite the need to identify both risk and protective factors for TBI in the general and at-risk populations [4, 14].”
BackgroundLee, M., Yang, K., Shyu, Y., Yuan, S.-S., Yang, C.-J., Lee, S.-Y., Lee, T., & Wang, L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.015 · Cited by 50 · cited 1×
“9%) [38], and including ATX use in our study resulted in the similar protective effect (not shown in table).”
ResultTai, Y., Gau, S. S., & Gau, C. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2012.11.027 · Cited by 50 · cited 1×
“, antipsychotics, hypnotics), may also increase the risk for injury [6, 11].”
BackgroundWiguna, T., Guerrero, A. P. S., Wibisono, S., & Sastroasmoro, S. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182452572 · Cited by 46 · cited 1×
“Neuroadaptive and neurochemical changes may explain the dosage effect of stimulants [32, 33].”
BackgroundChen, C., Yeh, H.-H. H., Chen, K.-H., Chang, I., Wu, E. C., & Lin, K. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0107 · Cited by 46 · cited 1×
“A population-based study followed patients with ADHD under 18 years old for 5 years in Taiwan and the retention rates for stimulant treatment declined after 3 months [23].”
BackgroundPharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder
Vaughan, B., & Kratochvil, C. J. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.005 · Cited by 46 · cited 1×
“Stimulants are highly effective in reducing ADHD symptoms in more than 70% of children [15]; the effect size of stimulants is one of the highest among all psychiatric medications.”
BackgroundRaman, S. R., Marshall, S. W., Haynes, K., Gaynes, B. N., Naftel, A. J., & Stürmer, T. (2013) · Injury Prevention · doi:10.1136/injuryprev-2012-040483 · Cited by 41
Ertan, C., Özcan, Ö. Ö., & Pepele, M. S. (2012) · Emergency Medicine Journal · doi:10.1136/emermed-2011-200298 · Cited by 40 · cited 1×
“In addition, individuals with ADHD are at a much higher risk for motor vehicle accidents and injuries, underscoring the public health significance of ADHD [7, 8].”
BackgroundRisk of ADHD After Multiple Exposures to General Anesthesia: A Nationwide Retrospective Cohort Study
Tsai, C.-J., Lee, C. T., Liang, S. H., Tsai, P.-J., Chen, V. C., & Gossop, M. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715587094 · Cited by 40 · cited 1×
“For rigorous diagnosis, we defined the ADHD cohort based on having two outpatient diagnoses of ADHD within 1 year or any inpatient diagnosis of ADHD [20].”
MethodSelf-citationHong, J., Novick, D., Treuer, T., Montgomery, W. S., Haynes, V. S., Wu, S.-H., & Haro, J. M. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s50628 · Cited by 38 · cited 1×
“Non-adherence with recommended dose and/or duration of stimulant therapy for individuals with ADHD has been amply reported [18, 19].”
Backgroundvan der Marel, K., Bouët, V., Meerhoff, G. F., Fréret, T., Boulouard, M., Dauphin, F., Klomp, A., Lucassen, P. J., Homberg, J. R., Dijkhuizen, R. M., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.044 · Cited by 36 · cited 1×
“In addition, functional MRI studies provide evidence that stimulant exposure may alter brain activation patterns and functional connectivity [34].”
BackgroundHsu, Y.-C., Chien, I., Tan, H. K., Lin, C., Cheng, S.-W., Chou, Y., & Chou, P. (2013) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-013-0702-2 · Cited by 20
Are We Doing Enough to Prevent the Perfect Storm? Novice Drivers, ADHD, and Distracted Driving
Winston, F. K., McDonald, C. C., & McGehee, D. V. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2013.2315 · Cited by 11
High Familial Correlation in Methylphenidate Response and Side Effect Profile
Gazer-Snitovsky, M., Brand‐Gothelf, A., Dubnov‐Raz, G., Weizman, A., & Gothelf, D. (2015) · Journal of Attention Disorders · doi:10.1177/1087054715580844 · Cited by 9 · cited 1×
“Available evidence indicates that the full therapeutic effect of stimulant treatment on ADHD core symptoms might not be observed until 24 weeks post-initiation of treatment, which provided an adequate dosage of stimulants [28, 29].”
BackgroundBali, V., Kamble, P., & Aparasu, R. R. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.6.486 · Cited by 8 · cited 1×
“However, children and adolescents with ADHD more likely received concomitant use of MPH and antipsychotics, if they presented with comorbid oppositional defiant disorder, conduct disorder, and autistic disorder [39].”
BackgroundDeficits in attention, motor control, and perception and increased risk of injury in children
Cairney, J. (2014) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12509 · Cited by 8 · cited 1×
“The core symptoms, along with other features of ADHD, likely account for increased injury risks [10].”
BackgroundSetyawan, J., Fridman, M., Hodgkins, P., Quintero, J., Erder, M. H., Katić, B., & Harpin, V. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0143-0 · Cited by 6 · cited 1×
“Increased adherence to stimulants is associated with improvements in core symptoms and cognitive performance in children and adolescents with ADHD [30, 31].”
Background
Research works printed but not linked: 1
- Lee MJ, Yang KC, Shyu YC, Yuan SS, Yang CJ, Lee SY, Lee TL, Wang LJ (2015) Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: a Nationwide Population-Based Study in Taiwan. J Affect Disord 189:110–117
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“163 A Taiwanese study of over 124,000 youths with ADHD found that methylphenidate treatment above an annual average cumulative defined daily dose of 84 halved the risk for traumatic brain injuries, after adjusting for confounders (Liao et al., 2018).”
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
Caye, A., Swanson, J. M., Coghill, D., & Rohde, L. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0116-3 · Cited by 303
A literature review and meta-analysis on the effects of ADHD medications on functional outcomes
Boland, H., DiSalvo, M., Fried, R., Woodworth, K. Y., Wilens, T., Faraone, S. V., & Biederman, J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.01.006 · Cited by 240
Chang, Z., Ghirardi, L., Quinn, P. D., Asherson, P., D’Onofrio, B. M., & Larsson, H. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.009 · Cited by 175
Attention-deficit/hyperactivity disorder and mortality risk in Taiwan.
Chen, V. C.-H., Chan, H.-L., Wu, S.-I., Lee, M., Lu, M.-L., Liang, H.-Y., Dewey, M. E., Stewart, R., & Lee, C. T.-C. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.8714 · Cited by 64
Self-citation
Metadata
- Authors
- Liao, Y.-T., Yang, Y.-H., Kuo, T.-Y., Liang, H.-Y., Huang, K.-Y., Wang, T.-N., Lee, Y., McIntyre, R. S., & Chen, V. C.-H.
- Affiliations
- Chung Shan Medical University Hospital (TW)
- National Taiwan University (TW)
- Chiayi Chang Gung Memorial Hospital (TW)
- Chung Shan Medical University (TW)
- Kaohsiung Medical University (TW)
- University Health Network (CA)
- Chang Gung University (TW)
- Corresponding author
- Chen, Vincent Chin-Hung
- ORCID
- Venue
- European Child & Adolescent Psychiatry
- Published
- 2017-08-30
- Volume
- 27
- Issue
- 3
- Pages
- 279-288
- ISSN
- 1018-8827 (ISSN-L)
- 1435-165X
- OpenAlex
- W2750862068
- Cited by
- 24
- References
- 40
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 2
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology, Taiwan
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- methylphenidate, traumatic brain injury, attention deficit hyperactivity disorder, stimulant medication, defined daily doses, drug dosing, injury prevention, children and adolescents, Taiwan
- MeSH terms
- Brain Injuries, Traumatic, Adolescent, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Methylphenidate, Risk, Taiwan, Drug Dosage Calculations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.